New tanshinone I derivatives S222 and S439 similarly inhibit topoisomerase I/II but reveal different p53-dependency in inducing G2/M arrest and apoptosis
文献类型：期刊论文
| 作者 | Tian, Qian-Ting1,2; Ding, Chun-Yong3 ; Song, Shan-Shan2; Wang, Ying-Qing2; Zhang, Ao3; Miao, Ze-Hong2
|
| 刊名 | BIOCHEMICAL PHARMACOLOGY
 |
| 出版日期 | 2018-08 |
| 卷号 | 154页码:255-264 |
| 关键词 | Tanshinone-1 S222 S439 Anticancer targets DNA topoisomerases P53 |
| ISSN号 | 0006-2952 |
| DOI | 10.1016/j.bcp.2018.05.006 |
| 文献子类 | Article |
| 英文摘要 | Tanshinone I (Tanshinone-1), a major active principle of the traditional Chinese medicine Salvia miltiorrhiza, possesses excellent anticancer properties, including inhibiting proliferation, angiogenesis and metastasis and overcoming multidrug resistance (MDR). However, its direct anticancer molecular target(s) remain unknown. Here we report that tanshinone-1 and its two new derivatives, S222 and S439, directly inhibit DNA topoisomerase I/II (Top1/2). With significantly improved water solubility, S222 and S439 displayed 12- and 14-times more potent proliferative inhibition than their parent tanshinone-1 in a panel of 15 cancer cell lines. Both retained tanshinone-1's anti-MDR and anti-angiogenesis properties and its capability to reduce the phosphorylation of Stat3 at Tyr705 with apparently enhanced efficacy and in these regards, S439 was also slightly more potent than S222. Both derivatives and tanshinone-1 directly inhibited Top1 and Top2 at molecular and cellular levels; the derivatives displayed similar potency but both were more potent than tanshinone-1. The inhibition of S222 and S439 on Top1 and Top2 was also more potent than that of the Top1 inhibitor hydroxylcamptothecin and the Top2 inhibitor etoposide, respectively. Consistently, tanshinone-1 and its derivatives induced DNA double-strand breaks, G2/M arrest and apoptosis Unexpectedly, the derivatives demonstrated different p53-dependency in inducing both cell cycle arrest and apoptosis. S222 showed no obvious p53 dependency. In contrast, S439 induced more G2/M arrest in p53 proficient cells than in p53 deficient cells while its apoptotic induction was the opposite. However, their proliferative inhibition was independent of the p53 status. Due to their structures different from the known Top1, Top2 and dual Top1/2 inhibitors, our results indicate that tanshinone-1 and its derivatives are a new type of dual Top1/2 inhibitors. |
| WOS关键词 | TUMOR-CELLS ; SALVICINE ; BIOMARKER ; CLEAVAGE ; PATHWAY ; GROWTH ; CYCLE ; VIVO |
| 资助项目 | Chinese Academy of Sciences[XDA12020331] |
| WOS研究方向 | Pharmacology & Pharmacy |
| 语种 | 英语 |
| WOS记录号 | WOS:000441369600026 |
| 出版者 | PERGAMON-ELSEVIER SCIENCE LTD |
| 源URL | [http://119.78.100.183/handle/2S10ELR8/279641]  |
| 专题 | 药理学第一研究室 中科院受体结构与功能重点实验室 新药研究国家重点实验室 药物化学研究室 |
| 通讯作者 | Wang, Ying-Qing; Zhang, Ao; Miao, Ze-Hong |
| 作者单位 | 1.Univ Chinese Acad Sci, 19A Yuquan Rd, Beijing 100049, Peoples R China 2.Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Div Antitumor Pharmacol, Shanghai 201203, Peoples R China; 3.Chinese Acad Sci, Shanghai Inst Mat Med, CAS Key Lab Receptor Res, Dept Med Chem, Shanghai 201203, Peoples R China; |
| 推荐引用方式 GB/T 7714 | Tian, Qian-Ting,Ding, Chun-Yong,Song, Shan-Shan,et al. New tanshinone I derivatives S222 and S439 similarly inhibit topoisomerase I/II but reveal different p53-dependency in inducing G2/M arrest and apoptosis[J]. BIOCHEMICAL PHARMACOLOGY,2018,154:255-264. |
| APA | Tian, Qian-Ting,Ding, Chun-Yong,Song, Shan-Shan,Wang, Ying-Qing,Zhang, Ao,&Miao, Ze-Hong.(2018).New tanshinone I derivatives S222 and S439 similarly inhibit topoisomerase I/II but reveal different p53-dependency in inducing G2/M arrest and apoptosis.BIOCHEMICAL PHARMACOLOGY,154,255-264. |
| MLA | Tian, Qian-Ting,et al."New tanshinone I derivatives S222 and S439 similarly inhibit topoisomerase I/II but reveal different p53-dependency in inducing G2/M arrest and apoptosis".BIOCHEMICAL PHARMACOLOGY 154(2018):255-264. |
入库方式： OAI收割
来源：上海药物研究所
浏览0
下载0
收藏0
其他版本
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。